Bioprinted 3D Cardiac Patches Could Reverse Scar Formation, Promote Myocardial Regeneration After Heart Attacks

Myocardial infarction, or heart attacks, play a large part in heart diseases and the necrosis of cardiac tissue. In APL Bioengineering, researchers take stock of stem cell-laden 3D-bioprinted cardiac patch technologies and their efficacy as a therapeutic and regenerative approach for ischemic cardiomyopathy in reversing scar formation and promoting myocardial regeneration. They explore types of candidate stem cells that possess cardiac regenerative potential and share updates on the challenging implementation of the state-of-the-art 3D-bioprinting approach.

FRESH 3D-Printing Platform Paves Way for Tissues, Organs

Research into 3D bioprinting has grown rapidly in recent years as scientists seek to re-create the structure and function of complex biological systems from human tissues to entire organs. In APL Bioengineering, researchers from Carnegie Mellon University provide perspective on the Freefrom Reversible Embedding of Suspended Hydrogels 3D bioprinting approach, which solves the issue of gravity and distortion by printing within a yield-stress support bath that holds the bioinks in place until they are cured.

UTEP Awarded $1.2 Million by NIH to Advance Research on Diabetes-Related Cardiac Complications

November is National Diabetes Month, a time when the nation comes together to shed light on one of the leading causes of death and disability among U.S. citizens. The University of Texas at El Paso (UTEP) is joining the fight against the disease through innovative research made possible through a recent $1.2M grant by the National Institutes of Health to advance understanding of a critical diabetic heart condition.